Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, USA.
Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, USA; Fred and Pamela Buffett Cancer Center, Omaha, NE, USA; Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE, USA.
Semin Cancer Biol. 2022 Nov;86(Pt 2):499-510. doi: 10.1016/j.semcancer.2022.03.021. Epub 2022 Mar 26.
Pancreatic ductal adenocarcinoma (PDAC) tumor microenvironment (TME) consists of multiple cell types interspersed by dense fibrous stroma. These cells communicate through low molecular weight signaling molecules called cytokines. The cytokines, through their receptors, facilitate PDAC initiation, progression, metastasis, and distant colonization of malignant cells. These signaling mediators secreted from tumor-associated macrophages, and cancer-associated fibroblasts in conjunction with oncogenic Kras mutation initiate acinar to ductal metaplasia (ADM), resulting in the appearance of early preneoplastic lesions. Further, M1- and M2-polarized macrophages provide proinflammatory conditions and promote deposition of extracellular matrix, whereas myofibroblasts and T-lymphocytes, such as Th17 and T-regulatory cells, create a fibroinflammatory and immunosuppressive environment with a significantly reduced cytotoxic T-cell population. During PDAC progression, cytokines regulate the expression of various oncogenic regulators such as NFκB, c-myc, growth factor receptors, and mucins resulting in the formation of high-grade PanIN lesions, epithelial to mesenchymal transition, invasion, and extravasation of malignant cells, and metastasis. During metastasis, PDAC cells colonize at the premetastatic niche created in the liver, and lung, an organotropic function primarily executed by cytokines in circulation or loaded in the exosomes from the primary tumor cells. The indispensable contribution of these cytokines at every stage of PDAC tumorigenesis makes them exciting candidates in combination with immune-, chemo- and targeted radiation therapy.
胰腺导管腺癌 (PDAC) 的肿瘤微环境 (TME) 由多种细胞类型组成,这些细胞被密集的纤维基质分隔开。这些细胞通过称为细胞因子的低分子量信号分子进行交流。细胞因子通过其受体促进 PDAC 的起始、进展、转移和恶性细胞的远处定植。这些信号介质由肿瘤相关巨噬细胞和癌相关成纤维细胞与致癌 Kras 突变一起分泌,启动腺泡到导管的化生 (ADM),导致早期癌前病变的出现。此外,M1 和 M2 极化的巨噬细胞提供促炎条件并促进细胞外基质的沉积,而肌成纤维细胞和 T 淋巴细胞,如 Th17 和 T 调节细胞,则形成纤维炎性和免疫抑制性环境,导致细胞毒性 T 细胞群体显著减少。在 PDAC 进展过程中,细胞因子调节各种致癌调节剂的表达,如 NFκB、c-myc、生长因子受体和粘蛋白,导致高级别 PanIN 病变、上皮到间充质转化、侵袭和恶性细胞的渗出以及转移的形成。在转移过程中,PDAC 细胞在肝脏和肺部预先形成的转移前生态位中定植,这一器官趋向性功能主要由循环中的细胞因子或来自原发性肿瘤细胞的外泌体中的细胞因子执行。这些细胞因子在 PDAC 肿瘤发生的每个阶段都做出了不可或缺的贡献,这使得它们成为与免疫、化疗和靶向放疗相结合的有吸引力的候选物。